[1] Pares A,Caballeria L,Rodes J,et al. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis:results of a double blind controlled multicentric trial. UDCA Cooperative Group from the Spanish Association for the Study of the Liver.Hepatology,2000,32:561-566.
[2] Corpechot C,Carrat F,Bonnand AM,et al. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhoss. J Hepatol,2000,32:1196-1199.
[3] Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases:practice guidelines. Hepatology,2000,31:1005-1013.
[4] Mackay IR,Gershwin ME. The nature of autoimmune disease.Semin Liver Dis,1997,17（1）:3-11.
[5] Metcalf J,Mitchison H,Palmer J,et al. Natural history of early primary biliary cirrhosis. Lancet,1996,348:1399-1402.
[6] 杨永林,杨建平. 原发性胆汁性肝硬化早期诊断15例. 世界华人消化杂志,2008,16（29）:3335-3337.
[7] Zein C,Boe G,Donlinger J,et al. The role of liver biopsy in the diagnosis of primary biliary cirrhoss. Hepatology,2001,34（pt2）:343A.
[8] 汪磊,谢渭芬,蔡雄. 70例原发性胆汁性肝硬化的临床表现. 中华消化杂志,2005,25（7）:391-393.
[9] Lee YM,Kaplan MM. The natural history of PBC:has it changed. Semin Liver Dis,2005,25（3）:321-326.
[10] Sorda J,Findor J. Methotrexate therapy in primary biliary cirrhosis. Acta Gastroenterol Latinoam,2000,30（4）:221-225.
[11] Roda E,Azzaroli F,Nigro G,et al. Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis. Dig Liver Dis,2002,34（7）：523-527.
[12] Lindor K. Ursodeoxycholic acid for the treatment of primary cirrhosis. N Engl J Med,2007,357:1524-1529.
[13] 王贵强.原发性胆汁性肝硬化及其临床诊治.中国实用内科杂志,2006,26:1895-1861.
[14] 李文,吴诗品. 原发性胆汁性肝硬化50例临床分析. 实用肝脏病杂志,2008,11（3）:187-188. |
